v3.25.2
Net Loss Per Class A Common Share Attributable to Maravai LifeSciences Holdings, Inc. - Summary of Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Earnings Per Share [Abstract]        
Net loss $ (69,837) $ (18,420) $ (122,690) $ (41,100)
Less: loss attributable to common non-controlling interests 30,246 8,631 53,154 19,233
Net loss attributable to Maravai LifeSciences Holdings, Inc., basic (39,591) (9,789) (69,536) (21,867)
Net loss attributable to Maravai LifeSciences Holdings, Inc., diluted $ (39,591) $ (9,789) $ (69,536) $ (21,867)
Weighted average Class A common shares outstanding - basic (in shares) 144,236 135,842 143,833 134,088
Weighted average Class A common shares outstanding - diluted (in shares) 144,236 135,842 143,833 134,088
Net loss per Class A common share attributable to Maravai LifeSciences Holdings, Inc., basic (in usd per share) $ (0.27) $ (0.07) $ (0.48) $ (0.16)
Net loss per Class A common share attributable to Maravai LifeSciences Holdings, Inc., diluted (in usd per share) $ (0.27) $ (0.07) $ (0.48) $ (0.16)